TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/21 16:05 | 1/15/21 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Angelino Mark D. | MA | O | COO | M.d | 34 | 4.59 | 0 | 8 | 1 | 515 | D | ||||||||||||||
1/20/21 16:05 | 1/15/21 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Angelino Mark D. | MA | O | COO | S.d | -247 | 32.97 | 0 | -8 | -1 | 515 | D | ||||||||||||||
12/17/20 16:05 | 12/15/20 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Angelino Mark D. | MA | O | COO | M.d | 24 | 4.59 | 0 | 5 | 1 | 515 | D | ||||||||||||||
12/17/20 16:05 | 12/15/20 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Angelino Mark D. | MA | O | COO | S.d | -185 | 34.98 | 0 | -5 | -1 | 515 | D | ||||||||||||||
8/18/20 16:07 | 8/14/20 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Angelino Mark D. | MA | O | COO | M.d | 38 | 0.6000 | 0 | 63 | 14 | 515 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |